SOMNIGROUP INTERNATIONAL INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that SOMNIGROUP INTERNATIONAL INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $648.20M | Mar 1, 2018 |
| FY2017 | Sep 30, 2017 | $724.80M | Mar 1, 2018 |
| FY2017 | Jun 30, 2017 | $659.30M | Mar 1, 2018 |
| FY2017 | Mar 31, 2017 | $722.10M | Mar 1, 2018 |
| FY2017 | Dec 31, 2016 | $771.10M | Mar 1, 2018 |
| FY2017 | Sep 30, 2016 | $832.40M | Mar 1, 2018 |
| FY2017 | Jun 30, 2016 | $804.40M | Mar 1, 2018 |
| FY2017 | Mar 31, 2016 | $721.00M | Mar 1, 2018 |
| FY2017 | Dec 31, 2015 | $3.15B | Mar 1, 2018 |
| FY2016 | Sep 30, 2015 | $880.00M | Feb 24, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.48B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $4.93B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $4.93B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $4.92B | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $4.93B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $3.68B | Feb 17, 2023 |
| FY2019 | Dec 31, 2019 | $871.30M | Feb 24, 2020 |
| FY2019 | Sep 30, 2019 | $821.00M | Feb 24, 2020 |
| FY2019 | Jun 30, 2019 | $722.80M | Feb 24, 2020 |
| FY2019 | Mar 31, 2019 | $690.90M | Feb 24, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.18B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.03B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.99B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $2.05B | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $2.16B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $1.64B | Feb 17, 2023 |
| FY2019 | Dec 31, 2019 | $386.40M | Feb 24, 2020 |
| FY2019 | Sep 30, 2019 | $360.60M | Feb 24, 2020 |
| FY2019 | Jun 30, 2019 | $313.40M | Feb 24, 2020 |
| FY2019 | Mar 31, 2019 | $281.80M | Feb 24, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $384.10M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $384.30M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $368.10M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $455.70M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $624.50M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $348.80M | Feb 17, 2023 |
| FY2019 | Dec 31, 2019 | $46.20M | Feb 24, 2020 |
| FY2019 | Sep 30, 2019 | $73.30M | Feb 24, 2020 |
| FY2019 | Jun 30, 2019 | $41.60M | Feb 24, 2020 |
| FY2019 | Mar 31, 2019 | $28.40M | Feb 24, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $754.90M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $634.20M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $607.20M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $680.60M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $912.30M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $532.10M | Feb 17, 2023 |
| FY2019 | Dec 31, 2019 | $84.60M | Feb 24, 2020 |
| FY2019 | Sep 30, 2019 | $120.60M | Feb 24, 2020 |
| FY2019 | Jun 30, 2019 | $81.00M | Feb 24, 2020 |
| FY2019 | Mar 31, 2019 | $60.50M | Feb 24, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $32.90M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $30.80M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $30.60M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $29.20M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $27.30M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $23.10M | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $23.00M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $21.90M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $21.70M | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $26.70M | Feb 25, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $800.10M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $666.50M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $570.30M | Feb 27, 2026 |
| FY2022 | Dec 31, 2022 | $378.80M | Feb 17, 2023 |
| FY2022 | Dec 31, 2021 | $723.10M | Feb 17, 2023 |
| FY2022 | Dec 31, 2020 | $654.70M | Feb 17, 2023 |
| FY2017 | Dec 31, 2017 | $222.90M | Mar 1, 2018 |
| FY2017 | Dec 31, 2016 | $165.50M | Mar 1, 2018 |
| FY2017 | Dec 31, 2015 | $234.20M | Mar 1, 2018 |
| FY2016 | Dec 31, 2014 | $225.20M | Feb 24, 2017 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $166.90M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $97.30M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $185.40M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $306.50M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $123.30M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $111.30M | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $88.20M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $73.60M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $66.60M | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $61.90M | Feb 25, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.60B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $5.98B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $4.55B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $4.36B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $4.32B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $3.31B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $3.06B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $2.72B | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | $2.69B | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | $2.70B | Mar 1, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.48B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $5.41B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $4.22B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $4.37B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $4.03B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $2.80B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $2.70B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $2.50B | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | $2.58B | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | $2.73B | Mar 1, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $285.80M | Feb 22, 2022 |
| FY2021 | Dec 31, 2020 | $503.60M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $359.50M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $214.60M | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | $112.50M | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | ($44.90M) | Mar 1, 2018 |
| FY2016 | Dec 31, 2015 | $290.20M | Feb 24, 2017 |
| FY2015 | Dec 31, 2014 | $202.70M | Feb 12, 2016 |
| FY2015 | Dec 31, 2013 | $118.60M | Feb 12, 2016 |
| FY2015 | Dec 31, 2012 | $22.30M | Feb 12, 2016 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.60B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.07B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.08B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $1.06B | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $1.11B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $766.30M | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $732.30M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $723.00M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $732.70M | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $699.20M | Feb 25, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.83B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $3.57B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $3.28B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $2.99B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $2.60B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $2.05B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $1.70B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $1.51B | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | $1.42B | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | $1.26B | Mar 1, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $69.40M | Feb 17, 2023 |
| FY2022 | Dec 31, 2021 | $300.70M | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $65.00M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $64.90M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $45.80M | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | $41.10M | Feb 25, 2019 |
| FY2018 | Dec 31, 2016 | $64.60M | Feb 25, 2019 |
| FY2017 | Dec 31, 2015 | $153.90M | Mar 1, 2018 |
| FY2017 | Dec 31, 2014 | $62.50M | Mar 1, 2018 |
| FY2016 | Dec 31, 2013 | $81.00M | Feb 24, 2017 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.61B | Feb 27, 2026 |
| FY2024 | Dec 31, 2024 | $3.76B | Feb 28, 2025 |
| FY2023 | Dec 31, 2023 | $2.50B | Feb 16, 2024 |
| FY2022 | Dec 31, 2022 | $2.75B | Feb 17, 2023 |
| FY2021 | Dec 31, 2021 | $2.28B | Feb 22, 2022 |
| FY2020 | Dec 31, 2020 | $1.30B | Feb 19, 2021 |
| FY2019 | Dec 31, 2019 | $1.54B | Feb 24, 2020 |
| FY2019 | Dec 31, 2018 | $1.65B | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | $1.75B | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | $1.89B | Mar 1, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | 0 | Feb 19, 2021 |
| FY2017 | Dec 31, 2017 | 0 | Mar 1, 2018 |
| FY2017 | Sep 30, 2017 | 0 | Mar 1, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | 0 | Feb 19, 2021 |
| FY2017 | Dec 31, 2017 | 0 | Mar 1, 2018 |
| FY2017 | Sep 30, 2017 | 0 | Mar 1, 2018 |